NG Feeding Increase Risk of Diarrhea and Infection Within 48 Hours of Admission: BMC
A recent study published in BMC Gastroenterology unveiled the critical importance of selecting the appropriate method and timing for nutritional support in patients with acute pancreatitis (AP). While initiating nasogastric (NG) feeding within 48 hours of admission increases the risk of complications such as diarrhea and infection, it does not significantly impact mortality rates or the need for surgical intervention. Ming Wang and colleagues conducted this study to comprehensively compare NG and nasojejunal (NJ) feeding initiated within the first 48 hours of hospital admission. Their systematic analysis aims to equip clinicians with evidence-based insights to facilitate informed decisions regarding early nutritional management for AP patients.
Acute pancreatitis, a prevalent digestive disorder, involves inflammation and dysfunction of the pancreas, primarily caused in adults by gallstones and alcohol. These factors contribute significantly to the pathophysiological process leading to pancreatic inflammation and damage. Management strategies for AP have been extensively researched, focusing particularly on optimizing the timing and method of nutritional support. Early enteral nutrition (EN) is advocated to mitigate pancreatic stimulation, aid in the recovery of intestinal barrier function, and reduce complications associated with delayed feeding. However, the ongoing debate over whether nasogastric or nasojejunal feeding routes are superior during this crucial early phase remains unresolved.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.